Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Johnson & Johnson Joins World Health Organization in Efforts to Prevent Spread of Ebola in West Africa
Johnson & Johnson (NYSE: JNJ) (the Company) today announced the World Health Organization (WHO) and […]
Cue Health Announces Completion of $235 Million Private Financing to Accelerate Growth
Cue Health Inc. (“Cue Health” or “Cue”), a health technology company, today announced the closing […]
$50M Investment Caps DrFirst $135 Million Total
Health technology pioneer DrFirst today announced the closing of a $50 million equity investment from Sixth Street Growth, […]
Exscientia Announces Second Molecule Created Using AI from Sumitomo Dainippon Pharma Collaboration to Enter Phase 1 Clinical Trial
Exscientia Ltd. (Headquarters: Oxford, UK; CEO: Andrew Hopkins) is pleased to acknowledge that Sumitomo Dainippon Pharma Co., […]
New Research to Study Benefits of Personalised Pacemaker Programming
Researchers BHF have funded at the University of Leeds will investigate how people living with […]
Moderna Announces New Supply Agreement with Australia for 25 Million Doses of its COVID-19 Vaccine
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
NHS’s £160M Accelerator Sites to Tackle Waiting Lists
The NHS has today announced a £160 million initiative to tackle waiting lists and develop […]
Babylon: Meet the Largest Digital-First, Value-Based Care Provider in the United States
Babylon today announced that its recent strategic partnerships and acquisitions — combined with significant organic […]
Pink Luminous Breast (PLB) Takes Steps Toward FDA Class III Approval
Pink Luminous Breast (PLB) is continuing to make strides in breast cancer awareness with a new […]
VXPASS Selected to Manage and Verify Digital Records for COVID-19 Vaccination Rollout for Kingdom of Lesotho
VXPASS, a blockchain-based platform built to manage, store and verify records for global COVID-19 vaccination […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more